2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell CarcinomaRecruitingPhase 32026-04-13NCT07524452
Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With OligometastasesOligo-metastatic CancerRecruitingPhase 32026-04-02NCT07481799